Angiotensin-converting enzyme inhibitors for bevacizumab-induced hypertension

被引：65

作者：

Dincer, Murat ^{[1
]}

Altundag, Kadri ^{[1
]}

机构：

[1] Hacettepe Univ, Inst Oncol, Dept Med Oncol, TR-06100 Ankara, Turkey

来源：

ANNALS OF PHARMACOTHERAPY | 2006年 / 40卷 / 12期

关键词：

D O I：

10.1345/aph.1H244

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：2278 / 2279

页数：2

共 5 条

[1] Targeted therapy of colorectal cancer: Clinical experience with bevacizumab [J].

Fernando, NH ;

Hurwitz, HI .

ONCOLOGIST, 2004, 9 :11-18

[2] Managing patients treated with bevacizumab combination therapy [J].

Gordon, MS ;

Cunningham, D .

ONCOLOGY, 2005, 69 :25-33

[3]

Hara A, 2006, KIDNEY INT, V69, P1986, DOI 10.1038/sj.ki.5000439

[4] Vascular endothelial growth factor in ischemia for vascular angiogenesis [J].

Henry, TD ;

Annex, BH ;

McKendall, GR ;

Azrin, MA ;

Lopez, JJ ;

Giordano, FJ ;

Shah, PK ;

Willerson, JT ;

Benza, RL ;

Berman, DS ;

Gibson, CM ;

Bajamonde, A ;

Rundle, AC ;

Fine, J ;

McCluskey, ER .

CIRCULATION, 2003, 107 (10) :1359-1365

[5] Experimental study of the drag force acting on a heated particle [J].

Katoshevski, D ;

Zhao, B ;

Ziskind, G ;

Bar-Ziv, E .

JOURNAL OF AEROSOL SCIENCE, 2001, 32 (01) :73-86

← 1 →